Outcomes of ER and metachronous cancer after ER for adenocarcinoma of the esophagogastric junction

Post written by Seiichiro Abe, MD, PhD, from the Endoscopy Division, National Cancer Center Hospital, Tokyo, Japan. Endoscopic resection (ER) is a minimally invasive treatment option for superficial adenocarcinoma (EA). We recently demonstrated that lymphovascular involvement, a poorly differentiated histology, and lesion size were independent risk factors for metastasis in patients with esophageal adenocarcinoma. Patients …

Continue reading Outcomes of ER and metachronous cancer after ER for adenocarcinoma of the esophagogastric junction